Yet it has to be stated that other NSAIDs used in RA treatment are also known to promote Compound II accumulation of MPO [66,67], showing the ambivalent immunological role of MPO and its HOCl-producing activity in RA. Here, MPO is linked to rheumatoid arthritis.